• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于非感染性葡萄膜炎的局部抗炎药:当前治疗方法与展望

Topical Anti-Inflammatory Agents for Non-Infectious Uveitis: Current Treatment and Perspectives.

作者信息

Balasubramaniam Balini, Chong Yu Jeat, Azzopardi Matthew, Logeswaran Abison, Denniston Alastair K

机构信息

Ophthalmology Department, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK.

Birmingham & Midland Eye Centre, Birmingham, B18 7QH, UK.

出版信息

J Inflamm Res. 2022 Nov 28;15:6439-6451. doi: 10.2147/JIR.S288294. eCollection 2022.

DOI:10.2147/JIR.S288294
PMID:36467992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9717596/
Abstract

Non-infectious uveitis represents a heterogenous group of immune-mediated ocular diseases, which can be associated with underlying systemic disease. While the initial choice of treatment of non-infectious uveitis depends on a number of factors such as anatomical location and degree of inflammation, topical therapies often remain the initial choice of non-invasive therapy. In this narrative review, we aim to describe the literature on non-infectious uveitis, with specific focus on the current perspective on topical anti-inflammatory therapy.

摘要

非感染性葡萄膜炎是一组由免疫介导的异质性眼部疾病,可能与潜在的全身性疾病相关。虽然非感染性葡萄膜炎的初始治疗选择取决于多种因素,如解剖位置和炎症程度,但局部治疗通常仍是无创治疗的首选。在这篇叙述性综述中,我们旨在描述有关非感染性葡萄膜炎的文献,特别关注局部抗炎治疗的当前观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ebc/9717596/8f46b3ecdb3b/JIR-15-6439-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ebc/9717596/e130fcd7f786/JIR-15-6439-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ebc/9717596/8f46b3ecdb3b/JIR-15-6439-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ebc/9717596/e130fcd7f786/JIR-15-6439-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ebc/9717596/8f46b3ecdb3b/JIR-15-6439-g0002.jpg

相似文献

1
Topical Anti-Inflammatory Agents for Non-Infectious Uveitis: Current Treatment and Perspectives.用于非感染性葡萄膜炎的局部抗炎药:当前治疗方法与展望
J Inflamm Res. 2022 Nov 28;15:6439-6451. doi: 10.2147/JIR.S288294. eCollection 2022.
2
[Topical Corticosteroids and Non-steroidal Anti-inflammatory Drugs in the Therapy of Non-infectious Uveitis].[局部用皮质类固醇和非甾体抗炎药治疗非感染性葡萄膜炎]
Klin Monbl Augenheilkd. 2018 May;235(5):586-591. doi: 10.1055/a-0590-4546. Epub 2018 May 8.
3
The Role of Corticosteroids and Immunomodulatory Therapy in the Management of Infectious Uveitis.皮质类固醇和免疫调节疗法在感染性葡萄膜炎治疗中的作用。
Ocul Immunol Inflamm. 2024 Oct;32(8):1832-1843. doi: 10.1080/09273948.2023.2296032. Epub 2024 Feb 8.
4
Update on the principles and novel local and systemic therapies for the treatment of non-infectious uveitis.非感染性葡萄膜炎治疗的原则及新型局部和全身疗法的最新进展
Inflamm Allergy Drug Targets. 2013 Feb;12(1):38-45. doi: 10.2174/1871528111312010006.
5
6
Current standardized therapeutic approach for uveitis in Japan.日本目前针对葡萄膜炎的标准化治疗方法。
Immunol Med. 2019 Sep;42(3):124-134. doi: 10.1080/25785826.2019.1678961. Epub 2019 Oct 24.
7
Therapies in Development for Non-Infectious Uveitis.非感染性葡萄膜炎的正在研发的疗法。
Curr Mol Med. 2015;15(6):565-77. doi: 10.2174/1566524015666150731103847.
8
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial.阿达木单抗预防皮质类固醇控制的非感染性活动性葡萄膜炎患者的葡萄膜炎发作(VISUAL II):一项多中心、双盲、随机、安慰剂对照的 3 期临床试验。
Lancet. 2016 Sep 17;388(10050):1183-92. doi: 10.1016/S0140-6736(16)31339-3. Epub 2016 Aug 16.
9
Optimising drug therapy for non-infectious uveitis.优化非感染性葡萄膜炎的药物治疗
Int Ophthalmol. 2019 Jul;39(7):1633-1650. doi: 10.1007/s10792-018-0984-1. Epub 2018 Jun 30.
10
[Diagnosis and treatment of non-infectious uveitis associated with systemic disease: a guide for internists].[与全身性疾病相关的非感染性葡萄膜炎的诊断与治疗:内科医生指南]
Rev Med Suisse. 2020 Oct 28;16(712):2059-2073.

引用本文的文献

1
Muscone Attenuates Uveitis Through the PI3K/AKT Signaling Pathway.麝香酮通过PI3K/AKT信号通路减轻葡萄膜炎。
Invest Ophthalmol Vis Sci. 2025 May 1;66(5):21. doi: 10.1167/iovs.66.5.21.
2
Impact of the Coronavirus Disease 2019 Pandemic on Initiation Therapy for Noninfectious Uveitis.2019年冠状病毒病大流行对非感染性葡萄膜炎起始治疗的影响
Ophthalmol Sci. 2025 Jan 27;5(4):100718. doi: 10.1016/j.xops.2025.100718. eCollection 2025 Jul-Aug.
3
Update on non-infectious uveitis treatment: anti-TNF-alpha and beyond.非感染性葡萄膜炎治疗的最新进展:抗肿瘤坏死因子-α及其他疗法

本文引用的文献

1
Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis.溴芬酸钠 0.09% 治疗非感染性葡萄膜炎继发的黄斑水肿。
Middle East Afr J Ophthalmol. 2021 Sep 25;28(2):98-103. doi: 10.4103/meajo.meajo_134_21. eCollection 2021 Apr-Jun.
2
Effects of topical low-dose preservative-free hydrocortisone on intraocular pressure in patients affected by ocular surface disease with and without glaucoma.局部小剂量无防腐剂的氢化可的松对伴有或不伴有青光眼的眼表疾病患者眼压的影响。
Graefes Arch Clin Exp Ophthalmol. 2022 Jan;260(1):247-253. doi: 10.1007/s00417-021-05345-3. Epub 2021 Aug 18.
3
Prevalence and Incidence of Uveitis: A Systematic Review and Meta-analysis.
Front Ophthalmol (Lausanne). 2024 Aug 2;4:1412930. doi: 10.3389/fopht.2024.1412930. eCollection 2024.
4
Design and Evaluation of a Dual-Sensitive In Situ Gel for the Controlled Release of Pranoprofen.设计并评价一种普洛萘普生双敏感原位凝胶,以控制药物释放。
AAPS PharmSciTech. 2024 Feb 8;25(2):35. doi: 10.1208/s12249-024-02748-3.
5
Ophthalmological Manifestations in Inflammatory Bowel Diseases: Keep an Eye on It.炎症性肠病的眼部表现:密切关注。
Cells. 2024 Jan 12;13(2):142. doi: 10.3390/cells13020142.
6
Local Myeloid-Derived Suppressor Cells Impair Progression of Experimental Autoimmune Uveitis by Alleviating Oxidative Stress and Inflammation.局部髓系来源的抑制细胞通过减轻氧化应激和炎症来抑制实验性自身免疫性葡萄膜炎的进展。
Invest Ophthalmol Vis Sci. 2023 Oct 3;64(13):39. doi: 10.1167/iovs.64.13.39.
7
A systematic review of ultrasound-mediated drug delivery to the eye and critical insights to facilitate a timely path to the clinic.超声介导眼部药物输送的系统评价及促进及时进入临床的关键见解。
Theranostics. 2023 Jun 19;13(11):3582-3638. doi: 10.7150/thno.82884. eCollection 2023.
葡萄膜炎的患病率和发病率:系统评价和荟萃分析。
Ophthalmic Epidemiol. 2021 Dec;28(6):461-468. doi: 10.1080/09286586.2021.1882506. Epub 2021 Feb 8.
4
Brimonidine-associated uveitis - a descriptive case series.布林佐胺相关性葡萄膜炎——描述性病例系列。
BMC Ophthalmol. 2020 Dec 17;20(1):489. doi: 10.1186/s12886-020-01762-w.
5
The effects of tropicamide and cyclopentolate hydrochloride on laser flare meter measurements in uveitis patients: a comparative study.托吡卡胺和盐酸环喷托酯对葡萄膜炎患者激光闪辉仪测量值的影响:一项对比研究。
Int Ophthalmol. 2021 Mar;41(3):853-857. doi: 10.1007/s10792-020-01639-3. Epub 2020 Nov 16.
6
Outcomes important to patients with non-infectious posterior segment-involving uveitis: a qualitative study.对非感染性累及后段葡萄膜炎患者重要的结局:一项定性研究。
BMJ Open Ophthalmol. 2020 Jul 21;5(1):e000481. doi: 10.1136/bmjophth-2020-000481. eCollection 2020.
7
Recent Advances in the Design of Topical Ophthalmic Delivery Systems in the Treatment of Ocular Surface Inflammation and Their Biopharmaceutical Evaluation.用于治疗眼表炎症的局部眼用给药系统的设计进展及其生物药剂学评价
Pharmaceutics. 2020 Jun 19;12(6):570. doi: 10.3390/pharmaceutics12060570.
8
Uveitis and cystoid macular oedema secondary to topical prostaglandin analogue use in ocular hypertension and open angle glaucoma.眼高压和开角型青光眼患者局部应用前列腺素类似物导致的葡萄膜炎和囊样黄斑水肿。
Br J Ophthalmol. 2020 Aug;104(8):1040-1044. doi: 10.1136/bjophthalmol-2019-315280. Epub 2020 Jun 12.
9
Vision loss in anterior uveitis.前葡萄膜炎导致的视力丧失。
Br J Ophthalmol. 2020 Dec;104(12):1652-1657. doi: 10.1136/bjophthalmol-2019-315551. Epub 2020 Apr 3.
10
Pathogenesis of Uveitic Glaucoma.葡萄膜炎性青光眼的发病机制
J Curr Glaucoma Pract. 2018 Sep-Dec;12(3):125-138. doi: 10.5005/jp-journals-10028-1257.